Andrew Spokes portfolio
Farallon Capital Management · Multi-strategy; founded by Tom Steyer
Farallon Capital Management's 13F filing for Q3 2026, filed with the SEC on November 16, 2026, reports $19.2B across 114 US-listed positions. The largest holding is RVMD at 14.4% of the portfolio; the ten largest make up 55%. The largest buy last quarter was Warner Bros Discovery Inc ($658.4M).
Key facts
- 13F portfolio value
- $19.2BQ3 2026
- Positions
- 114
- Largest holding
- RVMD 14.4%
- Top 10 share
- 55%
- New positions
- 48since Q2 2026
- Sold out
- 23
- Filed
- Nov 16, 2026
- Next 13F due
- Feb 15, 2027Q4 2026
Holdings as of (Q3 2026), filed with the SEC on . Changes are measured against the filing for Jun 30, 2026. Source: SEC EDGAR, Form 13F-HR of Farallon Capital Management (CIK 909661).
Prices as of .
Compared with Q2 2026, Andrew Spokes opened 48 new positions (ROKU, CRH, Super Micro Computer Inc…), added to 25, trimmed 20, sold out of 23 (Electronic Arts Inc, Crinetics Pharmaceuticals, Apogee Therapeutics Inc…).
By sector, Health Care is the largest at 55% of the reported portfolio, followed by Technology at 7%; 22% is in securities with no sector on file.
31 of the 114 positions listed have been in every one of the last 9 quarterly filings.
Andrew Spokes top holdings: stocks in the Q3 2026 13F
| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Price now | Since period end | Held | Last quarter |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Revolution Medicines IncRVMD | Health Care | 14.4% | $2.8B | 13.42M | $205.26 | $164.11 | 20.0% down | 9+ qtrs | ▼ Reduced 1.0% |
| 2 | Warner Bros Discovery Incno ticker on file | — | 7.96% | $1.5B | 49.37M | $30.95 | — | — | 4 qtrs | ▲ Added 76% |
| 3 | Natera IncNTRA | Health Care | 5.60% | $1.1B | 2.6M | $413.31 | $282.29 | 31.7% down | 9+ qtrs | ▲ Added 17% |
| 4 | Bridgebio Pharma IncBBIO | Health Care | 4.89% | $937.5M | 14.25M | $65.80 | $76.61 | 16.4% up | 9+ qtrs | ▲ Added 33% |
| 5 | Protagonist Therapeutics IncPTGX | Health Care | 4.73% | $907M | 6.44M | $140.89 | $124.80 | 11.4% down | 9+ qtrs | ▲ Added 1.4% |
| 6 | Exelixis IncEXEL | Health Care | 4.47% | $858.3M | 14.69M | $58.41 | $67.99 | 16.4% up | 9+ qtrs | ▲ Added 9.1% |
| 7 | Roivant Sciences LtdROIV · SHS | Health Care | 4.14% | $795.2M | 21.75M | $36.57 | $38.35 | 4.9% up | 9+ qtrs | ▲ Added 52% |
| 8 | Roku IncROKU | Communication | 3.30% | $633.5M | 4.16M | $152.28 | $160.52 | 5.4% up | 1 qtr | New |
| 9 | Amazon.com IncAMZN | Consumer Discretionary | 3.08% | $590.1M | 2.37M | $249.15 | $256.64 | 3.0% up | 6 qtrs | ▼ Reduced 10% |
| 10 | Grail IncGRAL | Health Care | 2.97% | $570.2M | 4.07M | $140.12 | $105.21 | 24.9% down | 6 qtrs | ▼ Reduced 2.2% |
| 11 | Boston Scientific CorpBSX | Health Care | 2.57% | $492.7M | 11.29M | $43.65 | $43.19 | 1.1% down | 9+ qtrs | ▲ Added 7.3% |
| 12 | Broadcom IncAVGO | Technology | 2.56% | $490.2M | 1.4M | $351.19 | $339.84 | 3.2% down | 4 qtrs | ▲ Added 21% |
| 13 | Crh PlcCRH · ORD | Materials | 2.31% | $442.2M | 5.34M | $82.80 | $91.84 | 10.9% up | 1 qtr | New |
| 14 | Kenvue IncKVUE | — | 2.30% | $441.8M | 25.02M | $17.66 | — | — | 4 qtrs | No change |
| 15 | Twist Bioscience CorpTWST | Health Care | 2.15% | $412.8M | 2.14M | $193.24 | $108.54 | 43.8% down | 9+ qtrs | No change |
| 16 | UnitedHealth Group IncUNH | Health Care | 2.01% | $384.9M | 1.05M | $367.08 | $397.58 | 8.3% up | 9+ qtrs | ▼ Reduced 17% |
| 17 | Microsoft CorpMSFT | Technology | 1.96% | $376.2M | 733.56K | $512.90 | $501.82 | 2.2% down | 9+ qtrs | ▼ Reduced 34% |
| 18 | Synopsys IncSNPS | Technology | 1.95% | $373.1M | 857.89K | $434.94 | $434.70 | 0.1% down | 4 qtrs | ▲ Added 3.4% |
| 19 | KKR & Co. IncKKR | Financials | 1.85% | $354.2M | 3.88M | $91.30 | $95.30 | 4.4% up | 4 qtrs | ▼ Reduced 5.8% |
| 20 | Aon PLCAON · SHS CL A | Financials | 1.79% | $343.1M | 1.24M | $276.77 | $337.64 | 22.0% up | 9+ qtrs | ▼ Reduced 10% |
| 21 | Strategy Incno ticker on file · NOTE 12/0 | — | 1.71% | $328.2M | — | — | — | — | 3 qtrs | ▲ Added 310% |
| 22 | Lantheus Holdings IncLNTH | Health Care | 1.61% | $309.7M | 3.11M | $99.53 | $101.85 | 2.3% up | 9+ qtrs | ▼ Reduced 44% |
| 23 | Thermo Fisher Scientific IncTMO | Health Care | 1.57% | $300.9M | 445.69K | $675.05 | $691.69 | 2.5% up | 9+ qtrs | ▼ Reduced 58% |
| 24 | Liquidia CorporationLQDA | — | 1.40% | $269.5M | 8.91M | $30.26 | $56.02 | 85.1% up | 9+ qtrs | ▲ Added 6.5% |
| 25 | WabtecWAB | Industrials | 1.31% | $252.1M | 877.9K | $287.18 | $292.65 | 1.9% up | 9+ qtrs | ▼ Reduced 1.9% |
| 26 | Beam Therapeutics IncBEAM | — | 1.31% | $251.3M | 10.28M | $24.45 | $20.88 | 14.6% down | 9+ qtrs | ▲ Added 0.4% |
| 27 | AramarkARMK | Consumer Discretionary | 1.29% | $246.7M | 4.61M | $53.55 | $56.90 | 6.3% up | 9+ qtrs | ▲ Added 27% |
| 28 | Immunovant IncIMVT | Health Care | 1.14% | $218.6M | 6.47M | $33.78 | $33.31 | 1.4% down | 9+ qtrs | ▲ Added 11% |
| 29 | Agios Pharmaceuticals IncAGIO | — | 1.03% | $197.5M | 5.94M | $33.25 | $29.34 | 11.8% down | 9+ qtrs | ▲ Added 0.4% |
| 30 | Biogen IncBIIB | Health Care | 0.80% | $153.8M | 680.87K | $225.88 | $250.96 | 11.1% up | 2 qtrs | ▲ Added 859% |
| 31 | Super Micro Computer Incno ticker on file · NOTE 3.500% 3/0 | — | 0.79% | $151.7M | — | — | — | — | 1 qtr | New |
| 32 | Johnson & JohnsonJNJ | Health Care | 0.66% | $127.2M | 480.43K | $264.74 | $280.51 | 6.0% up | 3 qtrs | ▲ Added 18% |
| 33 | Acadia Healthcare CompanyACHC | — | 0.66% | $126.7M | 4.61M | $27.50 | $38.44 | 39.8% up | 3 qtrs | ▲ Added 9.2% |
| 34 | Brightspring Health Services IncBTSG | Health Care | 0.60% | $116M | 2.04M | $56.75 | $69.85 | 23.1% up | 9+ qtrs | ▲ Added 18% |
| 35 | Tango Therapeutics IncTNGX | — | 0.59% | $113.5M | 4.55M | $24.95 | $22.54 | 9.7% down | 8 qtrs | ▼ Reduced 63% |
| 36 | Baidu IncBIDU · SPON ADR REP A | Technology | 0.55% | $104.6M | 1.2M | $86.87 | $71.63 | 17.5% down | 5 qtrs | No change |
| 37 | American Savings Bank NAASBH | — | 0.43% | $81.5M | 4.56M | $17.89 | $21.56 | 20.5% up | 1 qtr | New |
| 38 | Parabilis Medicines IncPBLS | — | 0.40% | $76.5M | 2.37M | $32.29 | $28.05 | 13.1% down | 2 qtrs | No change |
| 39 | AstraZeneca PLCAZN · ORD | Health Care | 0.37% | $71M | 440K | $161.47 | $183.33 | 13.5% up | 3 qtrs | ▼ Reduced 23% |
| 40 | JOYY IncJOYY · ADS REPSTG COM A | — | 0.34% | $65.8M | 820.2K | $80.25 | $79.06 | 1.5% down | 7 qtrs | ▲ Added 17% |
| 41 | Avalo Therapeutics IncAVTX | — | 0.32% | $60.9M | 3.97M | $15.33 | $6.99 | 54.4% down | 3 qtrs | ▲ Added 59% |
| 42 | Freenome IncFRNM | — | 0.31% | $58.8M | 3.73M | $15.75 | $9.99 | 36.6% down | 1 qtr | New |
| 43 | Ionic Digital IncIOND | — | 0.30% | $57.7M | 718.12K | $80.33 | $61.87 | 23.0% down | 1 qtr | New |
| 44 | Guardant Health IncGH | Health Care | 0.26% | $49.9M | 279.7K | $178.36 | $143.37 | 19.6% down | 6 qtrs | ▼ Reduced 13% |
| 45 | Strategy Incno ticker on file · NOTE 3/0 | — | 0.24% | $45.1M | — | — | — | — | 2 qtrs | ▲ Added more than 10× |
| 46 | Assembly Biosciences IncASMB | — | 0.20% | $37.7M | 1.6M | $23.49 | $22.00 | 6.3% down | 5 qtrs | No change |
| 47 | Novartis AGNVS · SPONSORED ADR | Health Care | 0.19% | $36.4M | 255K | $142.57 | $159.81 | 12.1% up | 2 qtrs | ▼ Reduced 30% |
| 48 | Maze Therapeutics IncMAZE | — | 0.16% | $30.1M | 1.11M | $27.18 | $33.08 | 21.7% up | 3 qtrs | No change |
| 49 | LB Pharmaceuticals IncLBRX | — | 0.15% | $28.5M | 741.41K | $38.38 | $39.91 | 4.0% up | 1 qtr | New |
| 50 | Immunocore Holdings plcIMCR · ADS | — | 0.15% | $28.1M | 928K | $30.29 | $27.91 | 7.9% down | 1 qtr | New |
| 51 | ASML Holding NVASML · N Y REGISTRY SHS | Technology | 0.13% | $24.5M | 13.52K | $1,811.67 | $1,364.11 | 24.7% down | 1 qtr | New |
| 52 | Rio Tinto PLCRIO · SPONSORED ADR | Materials | 0.11% | $20.6M | 218.9K | $94.17 | $79.96 | 15.1% down | 3 qtrs | ▲ Added 19% |
| 53 | Alibaba Group Holding LtdBABA · SPONSORED ADS | Consumer Discretionary | 0.11% | $20.3M | 189K | $107.54 | $86.99 | 19.1% down | 1 qtr | New |
| 54 | Electra Therapeutics IncETRA | — | 0.10% | $19.1M | 1.7M | $11.25 | $8.53 | 24.2% down | 1 qtr | New |
| 55 | Alvotech SAALVO · ORDINARY SHARES | — | 0.09% | $16.6M | 2.86M | $5.80 | $4.30 | 25.9% down | 9+ qtrs | No change |
| 56 | Indivior Pharmaceuticals IncSUPN | — | 0.08% | $16M | 447.62K | $35.85 | $29.14 | 18.7% down | 1 qtr | New |
| 57 | Alamar Biosciences IncALMR | — | 0.08% | $15.8M | 462.9K | $34.07 | $30.50 | 10.5% down | 2 qtrs | No change |
| 58 | NetEase IncNTES · SPONSORED ADS | Technology | 0.08% | $15M | 123.5K | $121.16 | $119.97 | 1.0% down | 3 qtrs | No change |
| 59 | Latigo Biotrapeutics IncLTGO | — | 0.07% | $14.2M | 850K | $16.70 | $13.18 | 21.1% down | 1 qtr | New |
| 60 | Abivax SAABVX · SPONSORED ADS | Health Care | 0.07% | $13.9M | 140K | $99.02 | $82.95 | 16.2% down | 5 qtrs | ▲ Added 15% |
| 61 | Kailera Therapeutics IncKLRA | — | 0.07% | $12.6M | 1.1M | $11.42 | $12.28 | 7.5% up | 2 qtrs | No change |
| 62 | Enanta Pharmaceuticals IncENTA | — | 0.07% | $12.5M | 950K | $13.18 | $8.89 | 32.6% down | 9+ qtrs | ▼ Reduced 61% |
| 63 | Vnet Group IncVNET · SPONSORED ADS A | — | 0.06% | $11.2M | 2.03M | $5.55 | $2.57 | 53.7% down | 9+ qtrs | ▲ Added 1.7% |
| 64 | Taysha Gene Therapies IncTSHA | — | 0.06% | $11M | 2.25M | $4.87 | $4.01 | 17.7% down | 2 qtrs | ▼ Reduced 0.04% |
| 65 | Minerva Neurosciences IncNERV | — | 0.04% | $7.9M | 2.37M | $3.35 | $2.13 | 36.4% down | 4 qtrs | No change |
| 66 | Scribe Therapeutics IncSCTX | — | 0.04% | $7M | 380K | $18.41 | $15.59 | 15.3% down | 1 qtr | New |
| 67 | Cohu IncCOHU | — | 0.03% | $6.2M | 91K | $68.14 | $39.88 | 41.5% down | 1 qtr | New |
| 68 | Inflarx NVIFRX | — | 0.03% | $6M | 3.31M | $1.80 | $1.14 | 36.7% down | 2 qtrs | ▼ Reduced 0.5% |
| 69 | Super Micro Computer Incno ticker on file · NOTE 2.250% 7/1 | — | 0.03% | $5.9M | — | — | — | — | 1 qtr | New |
| 70 | Entegris IncENTG | Materials | 0.03% | $5.7M | 37K | $154.06 | $142.16 | 7.7% down | 1 qtr | New |
| 71 | Braveheart Bio IncBRVE | — | 0.03% | $5.6M | 277.78K | $20.20 | $18.88 | 6.5% down | 1 qtr | New |
| 72 | Celestica IncCLS | Technology | 0.03% | $5.4M | 15K | $361.43 | $235.79 | 34.8% down | 1 qtr | New |
| 73 | Revvity IncRVTY | Health Care | 0.03% | $5.4M | 35K | $152.89 | $150.47 | 1.6% down | 1 qtr | New |
| 74 | Veeva Systems IncVEEV · CL A COM | Technology | 0.03% | $5.3M | 18.5K | $285.45 | $293.18 | 2.7% up | 1 qtr | New |
| 75 | Rockwell Automation IncROK | Industrials | 0.03% | $5.2M | 12K | $435.33 | $390.79 | 10.2% down | 1 qtr | New |
| 76 | Gates IndustrialGTES | Industrials | 0.03% | $5.1M | 196K | $26.20 | $24.86 | 5.1% down | 1 qtr | New |
| 77 | Mcgraw Hill IncMH | — | 0.03% | $5.1M | 389K | $13.11 | $11.45 | 12.7% down | 1 qtr | New |
| 78 | Ecolab IncECL | Materials | 0.03% | $5.1M | 18.5K | $274.58 | $308.44 | 12.3% up | 1 qtr | New |
| 79 | Worthington Enterprises IncWOR | — | 0.03% | $5.1M | 85K | $59.54 | $57.80 | 2.9% down | 1 qtr | New |
| 80 | Ati IncATI | Materials | 0.03% | $5M | 26.5K | $189.40 | $171.84 | 9.3% down | 1 qtr | New |
| 81 | Builders Firstsource IncBLDR | Consumer Discretionary | 0.03% | $5M | 87K | $57.01 | $59.94 | 5.1% up | 1 qtr | New |
| 82 | Nike IncNKE · CL B | Consumer Discretionary | 0.03% | $5M | 140K | $35.40 | $37.80 | 6.8% up | 1 qtr | New |
| 83 | RPM International IncRPM | Materials | 0.03% | $4.9M | 50K | $98.67 | $104.69 | 6.1% up | 1 qtr | New |
| 84 | Companhia Paranaense de Enerno ticker on file · SPONSORED ADS | — | 0.03% | $4.9M | 395K | $12.42 | — | — | 1 qtr | New |
| 85 | Magna International IncMGA | Consumer Discretionary | 0.03% | $4.9M | 77K | $63.67 | $62.51 | 1.8% down | 1 qtr | New |
| 86 | Woodside Energy Group LtdWDS · SPONSORED ADR | — | 0.03% | $4.9M | 220K | $22.17 | $20.47 | 7.7% down | 1 qtr | New |
| 87 | Modine Manufacturing CoMOD | Consumer Discretionary | 0.03% | $4.9M | 26K | $187.20 | $128.65 | 31.3% down | 1 qtr | New |
| 88 | Factset Resh Systems IncFDS | Technology | 0.03% | $4.9M | 18K | $269.95 | $319.67 | 18.4% up | 1 qtr | New |
| 89 | Nextpower IncNXT | Technology | 0.03% | $4.8M | 62K | $77.93 | $84.01 | 7.8% up | 1 qtr | New |
| 90 | Vesta Real Estate CorpVTMX · ADS | — | 0.03% | $4.8M | 150K | $32.18 | $37.36 | 16.1% up | 1 qtr | New |
| 91 | Expeditors International Wash IncEXPD | Industrials | 0.03% | $4.8M | 26K | $184.64 | $192.40 | 4.2% up | 1 qtr | New |
| 92 | Gxo Logistics IncorporatedGXO | Industrials | 0.03% | $4.8M | 108K | $44.45 | $56.95 | 28.1% up | 1 qtr | New |
| 93 | KBR IncKBR | Industrials | 0.03% | $4.8M | 136K | $35.16 | $35.32 | 0.5% up | 1 qtr | New |
| 94 | Flex LtdFLEX · ORD | Technology | 0.03% | $4.7M | 43K | $109.99 | $72.61 | 34.0% down | 1 qtr | New |
| 95 | Guidewire Software IncGWRE | Technology | 0.03% | $4.7M | 33K | $142.58 | $146.04 | 2.4% up | 1 qtr | New |
| 96 | Kraft Heinz CoKHC | Consumer Staples | 0.02% | $4.7M | 206K | $22.72 | $25.36 | 11.6% up | 1 qtr | New |
| 97 | Compania de Minas BuenaventuBVN · SPONSORED ADR | Materials | 0.02% | $4.7M | 148K | $31.58 | $23.46 | 25.7% down | 1 qtr | New |
| 98 | Lemonade IncLMND | — | 0.02% | $4.6M | 103K | $45.14 | $42.20 | 6.5% down | 1 qtr | New |
| 99 | Telix Pharmaceutical LtdTLX · SPONSORED ADS | — | 0.02% | $4.6M | 419K | $10.97 | $8.90 | 18.8% down | 1 qtr | New |
| 100 | Mobia Med IncMOBI | — | 0.02% | $4.1M | 437.83K | $9.45 | $12.62 | 33.5% up | 2 qtrs | ▼ Reduced 61% |
| 101 | Sagimet Biosciences IncSGMT | — | 0.02% | $4M | 400K | $9.88 | $9.91 | 0.3% up | 2 qtrs | ▼ Reduced 3.6% |
| 102 | Jatt III Acquisition CorpJTTT · ORD SHS | — | 0.02% | $3.9M | 350K | $11.16 | $10.23 | 8.3% down | 1 qtr | New |
| 103 | Goosehead Insurance IncGSHD | — | 0.02% | $3.8M | 84K | $45.36 | $49.80 | 9.8% up | 1 qtr | New |
| 104 | Prime Medicine IncPRME | — | 0.02% | $3.8M | 1.24M | $3.05 | $4.09 | 33.9% up | 9+ qtrs | No change |
| 105 | Jatt II Acquisition CorpJATT · ORD SHS | — | 0.02% | $3.3M | 300K | $11.12 | $10.20 | 8.3% down | 2 qtrs | No change |
| 106 | Summit Midstream CorporationSMC | — | 0.01% | $1.8M | 58.21K | $30.23 | $30.53 | 1.0% up | 9+ qtrs | No change |
| 107 | Revolution Medicines Incno ticker on file · *W EXP 12/17/202 | — | 0.01% | $1.4M | 120.09K | $11.46 | — | — | 9+ qtrs | No change |
| 108 | Cogent Biosciences IncCOGT | Health Care | 0.00% | $544.3K | 17K | $32.02 | $27.07 | 15.5% down | 9+ qtrs | No change |
| 109 | Welltower IncWELL | Real Estate | 0.00% | $230.2K | 1K | $230.24 | $242.74 | 5.4% up | 4 qtrs | No change |
| 110 | Pacific Biosciences of California IncPACB | — | 0.00% | $33.7K | 14.2K | $2.37 | $1.83 | 23.0% down | 9+ qtrs | No change |
| 111 | Geron CorpGERN | — | 0.00% | $17.7K | 14.4K | $1.23 | $0.9778 | 20.5% down | 9+ qtrs | No change |
| 112 | Rani Therapeutics Holdings-ARANI | — | 0.00% | $16.4K | 20.7K | $0.7910 | $0.5700 | 27.9% down | 4 qtrs | No change |
| 113 | Canopy Growth CorporationCGC | — | 0.00% | $16.1K | 18K | $0.8962 | $0.5378 | 40.0% down | 9+ qtrs | No change |
| 114 | Nvni Group Limitedno ticker on file · *W EXP 11/01/202 | — | 0.00% | $5.7K | 331.4K | $0.0172 | — | — | 9+ qtrs | ▼ Reduced 12% |
Andrew Spokes latest buys (Q3 2026)
Andrew Spokes latest sells (Q3 2026)
Every buy and sell in Andrew Spokes' Q3 2026 13F →
By sector
| Sector | Share of portfolio | Value | Positions |
|---|---|---|---|
| Health Care | 55.2% | $10.6B | 22 |
| Technology | 7.37% | $1.4B | 12 |
| Consumer Discretionary | 4.57% | $876.8M | 7 |
| Financials | 3.63% | $697.3M | 2 |
| Communication | 3.30% | $633.5M | 1 |
| Materials | 2.54% | $488.3M | 7 |
| Industrials | 1.44% | $276.9M | 6 |
| Consumer Staples | 0.02% | $4.7M | 1 |
| Real Estate | 0.00% | $230.2K | 1 |
| No sector on file | 21.9% | $4.2B | 55 |
8 quarterly filings on file for Farallon Capital Management, back to Q4 2024: reported value, position counts, and every buy and sell quarter by quarter.
Filing history →All Q3 2026 13F filings →Questions about Andrew Spokes' portfolio
What stocks does Andrew Spokes own?
According to Farallon Capital Management's 13F filing for Q3 2026, the largest of its 114 US-listed positions are RVMD (14.4%), Warner Bros Discovery Inc (8.0%), NTRA (5.6%), BBIO (4.9%) and PTGX (4.7%). A 13F shows long positions only, as of the quarter's end.
What is Andrew Spokes' largest holding?
RVMD (Revolution Medicines Inc), worth $2.8B at the end of Q3 2026, or 14.4% of the $19.2B Farallon Capital Management reported.
What did Andrew Spokes buy last quarter?
In Q3 2026, compared with the filing for Q2 2026, the largest purchases were Warner Bros Discovery Inc (added, $658.4M), ROKU (new position, $633.5M), CRH (new position, $442.2M), ROIV (added, $272M) and Strategy Inc (added, $248.2M).
What did Andrew Spokes sell last quarter?
In Q3 2026 the largest sales were Electronic Arts Inc (sold out, $1.6B), TMO (reduced, $407.4M), Crinetics Pharmaceuticals (sold out, $336.4M), LNTH (reduced, $246.1M) and MSFT (reduced, $194.5M), against the filing for Q2 2026.
How much is Andrew Spokes' portfolio worth?
Farallon Capital Management reported $19.2B in 114 US-listed positions for Q3 2026, valued at the quarter's end and filed on November 16, 2026. That is the 13F portfolio only: no cash, short positions or most shares listed outside the US.
When does Andrew Spokes file the next 13F?
The 13F for Q4 2026, the quarter ending December 31, 2026, is due by February 15, 2027: 45 days after the quarter ends, or the next business day. The latest filing on file here is for Q3 2026, filed on November 16, 2026.
Which sectors does Andrew Spokes own?
Health Care 55.2%, Technology 7.4%, Consumer Discretionary 4.6%, Financials 3.6%, Communication 3.3% of the reported portfolio, with 21.9% in securities that have no sector on file here (funds, smaller companies, positions without a ticker).
How long has Andrew Spokes held these stocks?
Counting consecutive quarterly filings up to Q3 2026: RVMD 9+, Warner Bros Discovery Inc 4, NTRA 9+, BBIO 9+, PTGX 9+, EXEL 9+. “9+” means the position is in every filing looked at, so it may go back further.
Learn
Cite this page
Funkfolio, “Andrew Spokes portfolio: Farallon Capital Management 13F holdings (Q3 2026)”, data as of 16 November 2026. https://funkfolio.com/gurus/farallon
Underlying data: SEC EDGAR, Form 13F-HR of Farallon Capital Management (CIK 909661) for the period ending September 30, 2026.
Source: SEC EDGAR, Form 13F-HR for Farallon Capital Management (CIK 909661), period ending Sep 30, 2026, filed Nov 16, 2026. “Last quarter” compares share counts with the filing for Jun 30, 2026. 2 option positions in the filing are not shown. “Reported price” is the position's reported value divided by its shares — the price the filing implies for the period end. “Price now” is from Yahoo Finance and can be delayed 15 minutes or more; “since period end” sets the two side by side and is left blank where the reported price falls outside the stock's 52-week range, which points to a share split since. A split small enough to stay inside that range is not caught, and dividends are not counted. Sectors are those of the ranked companies on this site; funds, smaller companies and positions without a ticker have none. “Held” counts consecutive quarterly filings the position appears in, out of the 9 looked at. A buy or sell is sized as the shares moved at the price the filing implies; a position sold out at its value in the previous filing. Filings can be 45 days old when published; this is not a live portfolio and not advice.